Skip to main content

Vasu V Sethuraman

NIH Rank #3101
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 79856274Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$3.2M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,101
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vasu V Sethuraman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Vasu V Sethuraman as a PI. Multi-PI records show the full award amount for context.

  • 4R44DK138869-02R44
    Polymer Epithelial Lining for the Oral Delivery of Macromolecules
    $1.2M
    award amount
  • 4R44DK141341-02R44
    Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery
    $916.4K
    award amount
  • 1R44HD118842-01A1R44
    Development of an Oral Methionine-Gamma-Lyase Enzyme for the Treatment of Homocystinuria
    $347K
    award amount
  • 1R44DK143766-01R44
    Development of Once-daily Oral Treatment for Maple Syrup Urine Disease
    $343.6K
    award amount
  • 1R44DK142244-01R44
    Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
    $325K
    award amount

Award organization

Organizations that administered FY2025 awards listing Vasu V Sethuraman as a PI.

FY2025 award administered by Syntis Bio Inc (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Syntis Bio Inc
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #3101
  6. 2025
    Entered Top 25% Nationally
    Ranked #3101
  7. 2026
    $5M Cumulative Funding